These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 22486062)

  • 1. [Chronic renal failure causes bone fragility and blood vessel stiffening].
    Keronen S; Martola L; Honkanen E
    Duodecim; 2012; 128(5):465-74. PubMed ID: 22486062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Off-label use of phosphate binders in non-dialysis-dependent CKD.
    Winkelmayer WC; Chertow GM
    Am J Kidney Dis; 2010 Nov; 56(5):813-6. PubMed ID: 20970022
    [No Abstract]   [Full Text] [Related]  

  • 3. [Control of phosphorus and treatment with vitamin D in chronic kidney disease prior to the start of dialysis].
    Sánchez González MC; Fernandez Giraldez E; Valdivielso Revilla JM
    Nefrologia; 2008; 28 Suppl 5():39-45. PubMed ID: 18847419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Uremic bone disease: current knowledge, controversial issues, and new horizons.
    Malluche HH; Monier-Faugere MC
    Miner Electrolyte Metab; 1991; 17(4):281-96. PubMed ID: 1813791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vitamin D retains an important role in the pathogenesis and management of secondary hyperparathyroidism in chronic renal failure.
    Cozzolino M; Gallieni M; Brancaccio D; Arcidiacono T; Bianchi G; Vezzoli G
    J Nephrol; 2006; 19(5):566-77. PubMed ID: 17136683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved patient outcomes in chronic kidney disease: optimizing vitamin D therapy.
    Gesek FA; Desmond JS
    Nephrol Nurs J; 2008; 35(2 Suppl):5S-22S; quiz 23S. PubMed ID: 18505229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimal management of bone mineral disorders in chronic kidney disease and end stage renal disease.
    Lundquist AL; Nigwekar SU
    Curr Opin Nephrol Hypertens; 2016 Mar; 25(2):120-6. PubMed ID: 26785065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Physiopathology of renal osteodystrophy. I. Patients with kidney failure without dialysis].
    Fournier A; Bordier P; Weil B; Safar M; Idatte JM
    Presse Med (1893); 1971 Oct; 79(45):2017-21. PubMed ID: 5119047
    [No Abstract]   [Full Text] [Related]  

  • 9. How KDIGO will (or will not) influence the management of hyperphosphatemia.
    Kovesdy CP
    Semin Dial; 2011; 24(1):35-6. PubMed ID: 21338391
    [No Abstract]   [Full Text] [Related]  

  • 10. [Renal osteodystrophy--more than a mere bone disease].
    Saha H
    Duodecim; 2001; 117(21):2181-7. PubMed ID: 12184205
    [No Abstract]   [Full Text] [Related]  

  • 11. Pathogenesis of bone and mineral related disorders in chronic kidney disease: key role of hyperphosphatemia.
    Román-García P; Carrillo-López N; Cannata-Andía JB
    J Ren Care; 2009 Mar; 35 Suppl 1():34-8. PubMed ID: 19222729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Mineral and bone disorder in chronic kidney disease].
    Matuszkiewicz-Rowińska J; Kulicki P
    Wiad Lek; 2014; 67(3):419-21. PubMed ID: 25782203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. When is Vitamin D contraindicated in dialysis patients?
    Lewin E; Olgaard K
    Semin Dial; 2009; 22(3):240-2. PubMed ID: 19572998
    [No Abstract]   [Full Text] [Related]  

  • 14. [Skeletal damage in chronic kidney failure].
    Ringe JD
    Med Klin Prax; 1982 Feb; 77(5):34-6. PubMed ID: 7043225
    [No Abstract]   [Full Text] [Related]  

  • 15. When is Vitamin D contraindicated in dialysis patients?
    Brown HJ; Cunningham J
    Semin Dial; 2009; 22(3):237-40. PubMed ID: 19572997
    [No Abstract]   [Full Text] [Related]  

  • 16. [Letter: Is it necessary to wait for the time of parathyroidectomy to treat the hyperparathyroidism of patients with chronic renal insufficiency].
    Bernheim J; Faivre JM
    Nouv Presse Med; 1975 Feb; 4(8):591. PubMed ID: 1129122
    [No Abstract]   [Full Text] [Related]  

  • 17. Renal osteodystrophy.
    Nephrol Nurse; 1979; 1(5):44-8. PubMed ID: 261215
    [No Abstract]   [Full Text] [Related]  

  • 18. Managing bone mineral disorders in CKD: an overview of current therapies.
    Delaney M
    J Ren Care; 2009 Mar; 35 Suppl 1():107-10. PubMed ID: 19222741
    [No Abstract]   [Full Text] [Related]  

  • 19. Calcium and phosphorus in diet therapy of uremia.
    Schoolwerth AC; Engle JE
    J Am Diet Assoc; 1975 May; 66(5):460-4. PubMed ID: 1123506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The problem and unanswered questions. Renal osteodystrophy, soft tissue calcification, and distrubed divalent ion metabolism in chronic renal failure.
    Kleeman CR; Massry SG; Coburn JW; Popovtzer MM
    Arch Intern Med; 1969 Sep; 124(3):262-8. PubMed ID: 5806039
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.